Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ·Healthcare·Biotechnology
$217.09
-1.62%
Mkt Cap $27.50B
Analyst Ratings
Buy
23
Hold
5
Sell
0
Price Target (69 analysts)
$454.27
Range $370.00 – $530.00
Implied Upside
+109.3%
Consensus $454.27 vs current $217.09